Metastatic glucagonoma presenting with weight loss and necrolytic migratory erythema

Author: Ketherine ¹ ; Maria Katrina Mallonga ¹ ; Mary Anne Calimon ¹ ; Armand Rosaurus Labitag ¹ ; Michael Villa ¹
Author Information

1. St.Lukes Medical Center, Quezon City - Philippines
Publication Type:Journal Article
MeSH: Glucagonoma; Necrolytic Migratory Erythema
From: Journal of the ASEAN Federation of Endocrine Societies 2015;30(2):174-177
CountryPhilippines
Language:English
Abstract: A 42-year-old Filipino female was admitted due to weight loss and recurrent abdominal pain over the past ten years. In 2010, she was diagnosed to have disseminated PTB associated with a liver mass. After 1 year of anti-TB treatment, lung condition was treated but her liver mass has enlarged. She also developed diarrhea, diabetes, and skin lesions with biopsy results showing Necrolytic Migratory Erythema (NME). CT scan showed liver and pancreatic tumors that were biopsied revealing a neuroendocrine tumor. Blood glucagon level was elevated. She was treated as a case of glucagon-secreting tumor with liver metastases with Everolimus and Octreotide. After 3 months of treatment, she gained weight, the skin lesions improved, and the liver mass decreased in size. Many of the initial symptoms of glucagonoma are nonspecific and subtle. As a result, glucagonoma is often diagnosed relatively late in the course of the disease. NME, the characteristic skin lesion of the glucagonoma syndrome, is often the clue that leads to the correct diagnosis.
Full text:250-Article Text-2884-1-10-20151204.pdf